Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00514670 · ClinicalTrials.gov registry record · NA

A Randomized Controlled Trial of a School Disinfection and Hand Hygiene Program

A NA study of Gastrointestinal Diseases and Respiratory Infections, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
285
Enrollment target
1
Study location

NCT00514670: Completed NA study of Gastrointestinal Diseases and Respiratory Infections, sponsored by Boston Children's Hospital.

NCT00514670 is a NA study of Gastrointestinal Diseases and Respiratory Infections that has completed, run by Boston Children's Hospital. The registered enrollment target is 285 participants, below the 36,397-participant average among 14 other Gastrointestinal Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00514670, a NA study of Gastrointestinal Diseases and Respiratory Infections, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
285 participants
Enrollment target
1
Study location

Study Summary

The objective of the trial is to assess the impact of a disinfection and hand hygiene program on absenteeism in elementary school classrooms. Students in intervention classrooms will use alcohol-based hand sanitizers at school, and their classrooms will be disinfected using quaternary ammonium wipes. We hypothesize that the use of disinfectants and hand hygiene products in elementary school classrooms will reduce absenteeism.

Interventions

  • OTHER Alcohol-based hand sanitizer & quaternary ammonium wipes

Study Locations (1)

Massachusetts

  • Children's Hospital Boston - Boston

Trial Details

FieldValue
Enrollment Target 285 participants
Start Date 2006-03
Est. Completion 2006-05
Phase NA
Boston Children's Hospital

462 total trials

What the finished NCT00514670 record still lists

NCT00514670 is an interventional study that assigns participants to a tested intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap, below the 36,397-participant average among 14 other Gastrointestinal Diseases trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Gastrointestinal Diseases appearing as the primary indexed condition, and to 1 intervention - of which Alcohol-based hand sanitizer & quaternary ammonium wipes is the first listed.

NCT00514670 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00514670 about?

NCT00514670 is a clinical study titled "A Randomized Controlled Trial of a School Disinfection and Hand Hygiene Program". The objective of the trial is to assess the impact of a disinfection and hand hygiene program on absenteeism in elementary school classrooms. Students in intervention classrooms will use alcohol-based hand sanitizers at school, and their classrooms will be disinfected using quaternary ammonium wipes...

What is the current status of trial NCT00514670?

This trial is currently completed. It is a NA study. The enrollment target is 285 participants. The study started on 2006-03. Estimated completion is 2006-05.

What conditions does trial NCT00514670 study?

This clinical trial studies the following conditions: Gastrointestinal Diseases, Respiratory Infections.

What interventions are being tested in trial NCT00514670?

The interventions under investigation include: Alcohol-based hand sanitizer & quaternary ammonium wipes (OTHER).

Who is sponsoring clinical trial NCT00514670?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00514670 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastrointestinal Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00514670's enrollment target sits among peer trials

285 7th of 14 higher than 8 of 14 other Gastrointestinal Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gastrointestinal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03412877 · 285 participants · Phase 2

    Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

  • NCT04537936 · 285 participants · NA

    Psychotherapy Intervention for Latinos With Adv Cancer

  • NCT04965675 · 285 participants · Phase 3

    A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

  • NCT05320835 · 285 participants · NA

    A Setting Focus Overdose Prevention Intervention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00514670, the US trial registry maintained by the National Library of Medicine. NCT00514670 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.